Stem-cell therapy for autism is not FDA-approved. No autism-specific stem-cell product has completed pivotal trials in the USA or EU; all offerings are investigational. Some overseas clinics market treatments as 'approved' or 'clinically proven' — these claims are false and a warning sign. Any autism therapy offered outside a registered trial is experimental, whatever the marketing says.
Autism Spectrum Disorder stems from alterations in neuronal connectivity and immune signalling during neurodevelopment. Stem-cell research explores whether mesenchymal stem cells derived from placental tissue or amniotic membrane can modulate neuroinflammation, support synaptic plasticity, and promote neural integration. These cells are selected because they secrete immunoregulatory factors and can differentiate into supportive glial cells. Neurogenic cells are also being studied to repair damaged neural circuits, while exosomes — extracellular vesicles released by stem cells — are examined as vehicles for delivering anti-inflammatory signals to the brain. Current approaches remain investigational; the evidence base comprises preclinical work and early clinical trials. No mechanism yet explains why or how stem cells would alter the core neurobiological features of autism in humans.
Am I a candidate? → · Autism Spectrum Disorder: full overview → · Autism Spectrum Disorder cost → · Cost →
Medically reviewed by StemCellAtlas’s editorial team with Kiian Nadiia, MD, PhD (Paediatric Neurologist · Medical Director, CSM Clinic Network · 12+ yrs in Autism Spectrum Disorders) of partner clinic Stem Plus (Sofia), against ISSCR, FDA & EMA guidance. Educational information, not medical advice; figures indicative.
位于欧盟核心的 GMP 认证再生医学诊所——费用 3,000–8,000 欧元起，仅为美国或德国价格的一小部分。为来自 50 多个国家的国际患者提供个性化方案。
免费医疗评估